Pacific Biosciences of California (PACB) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 04/24/20
Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government LabsGlobeNewsWire • 04/08/20
Statement on Jury Verdict in Delaware Trial Against Oxford Nanopore TechnologiesGlobeNewsWire • 03/18/20
Why Is Pacific Biosciences (PACB) Down 18.1% Since Last Earnings Report?Zacks Investment Research • 03/07/20
Christian Henry Appointed Chairman of Pacific Biosciences’ Board of DirectorsGlobeNewsWire • 03/05/20
Pacific Biosciences to Support Sequencing of California Species for the Earth BioGenome ProjectGlobeNewsWire • 02/25/20
Pacific Biosciences Announces Retirement of Michael Phillips, SVP of Research and DevelopmentGlobeNewsWire • 02/07/20
Pacific Biosciences of California, Inc. (PACB) CEO Mike Hunkapiller on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/07/20
Pacific Biosciences of California (PACB) Reports Break-Even Earnings for Q4Zacks Investment Research • 02/06/20
Pacific Biosciences of California (PACB) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 01/30/20
Pacific Biosciences (PACB) Up 2.7% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/07/19
Options Traders Expect Huge Moves in Pacific Biosciences (PACB) StockZacks Investment Research • 11/20/19
Will Pacific Biosciences of California (PACB) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 10/31/19
The U.K.'S Antitrust Regulator Seems Bent On Blocking The Pacific Biosciences - Illumina DealSeeking Alpha • 10/24/19